A Case of Childhood Blastic Phase Chronic Myeloid Leukemia with Minor BCR-ABL

Junko Yamanaka, Mariko Shimizu, Maho Sato, Masami Inoue, Motohiro Matsui, Hiroyuki Shimada, Hiroyuki Shichino

Research output: Contribution to journalArticle

Abstract

Chronic myeloid leukemia (CML) is commonly associated with major BCR-ABL transcript. We present a child with blastic phase CML associated with minor BCR-ABL transcript without prior CML diagnosis. Diagnosis was achieved by fluorescence in situ hybridization of peripheral blood neutrophils, which identified 90% as BCR-ABL positive. The patient received chemotherapy with imatinib followed by dasatinib and underwent reduced-intensity hematopoietic allogeneic stem cell transplantation with prophylactic posttransplant dasatinib for 2 years and has remained in complete molecular remission. Our intensified treatment regimen was effective compared with previous studies on minor BCR-ABL CML describing inferior outcomes with tyrosine kinase inhibitor therapy.

Original languageEnglish
JournalJournal of Pediatric Hematology/Oncology
DOIs
Publication statusPublished - 2019 Jan 1

Fingerprint

Leukemia, Myeloid, Chronic Phase
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Hematopoietic Stem Cell Transplantation
Fluorescence In Situ Hybridization
Protein-Tyrosine Kinases
Neutrophils
Drug Therapy
Therapeutics
Dasatinib

Keywords

  • blastic phase
  • chronic myeloid leukemia
  • minor BCR-ABL fusion gene transcription
  • reduced-intensity hematopoietic stem cell transplantation
  • tyrosine kinase inhibitor

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

A Case of Childhood Blastic Phase Chronic Myeloid Leukemia with Minor BCR-ABL. / Yamanaka, Junko; Shimizu, Mariko; Sato, Maho; Inoue, Masami; Matsui, Motohiro; Shimada, Hiroyuki; Shichino, Hiroyuki.

In: Journal of Pediatric Hematology/Oncology, 01.01.2019.

Research output: Contribution to journalArticle

Yamanaka, Junko ; Shimizu, Mariko ; Sato, Maho ; Inoue, Masami ; Matsui, Motohiro ; Shimada, Hiroyuki ; Shichino, Hiroyuki. / A Case of Childhood Blastic Phase Chronic Myeloid Leukemia with Minor BCR-ABL. In: Journal of Pediatric Hematology/Oncology. 2019.
@article{e1f245af87514a748717d59251808875,
title = "A Case of Childhood Blastic Phase Chronic Myeloid Leukemia with Minor BCR-ABL",
abstract = "Chronic myeloid leukemia (CML) is commonly associated with major BCR-ABL transcript. We present a child with blastic phase CML associated with minor BCR-ABL transcript without prior CML diagnosis. Diagnosis was achieved by fluorescence in situ hybridization of peripheral blood neutrophils, which identified 90{\%} as BCR-ABL positive. The patient received chemotherapy with imatinib followed by dasatinib and underwent reduced-intensity hematopoietic allogeneic stem cell transplantation with prophylactic posttransplant dasatinib for 2 years and has remained in complete molecular remission. Our intensified treatment regimen was effective compared with previous studies on minor BCR-ABL CML describing inferior outcomes with tyrosine kinase inhibitor therapy.",
keywords = "blastic phase, chronic myeloid leukemia, minor BCR-ABL fusion gene transcription, reduced-intensity hematopoietic stem cell transplantation, tyrosine kinase inhibitor",
author = "Junko Yamanaka and Mariko Shimizu and Maho Sato and Masami Inoue and Motohiro Matsui and Hiroyuki Shimada and Hiroyuki Shichino",
year = "2019",
month = "1",
day = "1",
doi = "10.1097/MPH.0000000000001488",
language = "English",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - A Case of Childhood Blastic Phase Chronic Myeloid Leukemia with Minor BCR-ABL

AU - Yamanaka, Junko

AU - Shimizu, Mariko

AU - Sato, Maho

AU - Inoue, Masami

AU - Matsui, Motohiro

AU - Shimada, Hiroyuki

AU - Shichino, Hiroyuki

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Chronic myeloid leukemia (CML) is commonly associated with major BCR-ABL transcript. We present a child with blastic phase CML associated with minor BCR-ABL transcript without prior CML diagnosis. Diagnosis was achieved by fluorescence in situ hybridization of peripheral blood neutrophils, which identified 90% as BCR-ABL positive. The patient received chemotherapy with imatinib followed by dasatinib and underwent reduced-intensity hematopoietic allogeneic stem cell transplantation with prophylactic posttransplant dasatinib for 2 years and has remained in complete molecular remission. Our intensified treatment regimen was effective compared with previous studies on minor BCR-ABL CML describing inferior outcomes with tyrosine kinase inhibitor therapy.

AB - Chronic myeloid leukemia (CML) is commonly associated with major BCR-ABL transcript. We present a child with blastic phase CML associated with minor BCR-ABL transcript without prior CML diagnosis. Diagnosis was achieved by fluorescence in situ hybridization of peripheral blood neutrophils, which identified 90% as BCR-ABL positive. The patient received chemotherapy with imatinib followed by dasatinib and underwent reduced-intensity hematopoietic allogeneic stem cell transplantation with prophylactic posttransplant dasatinib for 2 years and has remained in complete molecular remission. Our intensified treatment regimen was effective compared with previous studies on minor BCR-ABL CML describing inferior outcomes with tyrosine kinase inhibitor therapy.

KW - blastic phase

KW - chronic myeloid leukemia

KW - minor BCR-ABL fusion gene transcription

KW - reduced-intensity hematopoietic stem cell transplantation

KW - tyrosine kinase inhibitor

UR - http://www.scopus.com/inward/record.url?scp=85065328523&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065328523&partnerID=8YFLogxK

U2 - 10.1097/MPH.0000000000001488

DO - 10.1097/MPH.0000000000001488

M3 - Article

C2 - 30994506

AN - SCOPUS:85065328523

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

ER -